OM
Outset Medical, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$4.19
−3.46%Year over year
Reported trailing growth
- Revenue
- -1.3%
- EBITDA
- +14.8%
- EBIT
- +16.4%
- EPS
- +83.1%
- Free cash flow
- +43.2%
- Operating cash flow
- +43.3%
Forward estimates
Based on analyst estimates
- Revenue
- +13.2%
- EBITDA
- +41.1%
- EPS
- +34.4%
Three-year CAGR
- Revenue
- +1.2%
- EBITDA
- +38.9%
- EBIT
- +41.2%
- Net income
- +36.2%
- EPS
- +85.5%
- Free cash flow
- +59.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026